Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
Terri P McVeigh, Michael J Kerin Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway, Galway, Republic of Ireland Abstract: Implementation of the Oncotype DX assay has led to a change in the manner in which chemotherapy is utilized in pat...
Enregistré dans:
Auteurs principaux: | McVeigh TP, Kerin MJ |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4019693c5b824749a62d1efb2f4690df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling
par: Ilana Schlam, et autres
Publié: (2021) -
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
par: Richard Buus, et autres
Publié: (2021) -
X-RAY DIAGNOSTICS OF PATHOLOGY OF MUSCULOSKELETAL SYSTEM USING DX-D FULL LEG FULL SPINE SYSTEM
par: N. A. Pozdeeva, et autres
Publié: (2013) -
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor
par: García,Patricia, et autres
Publié: (2020) -
A Review of Breast Cancer Risk Factors in Adolescents and Young Adults
par: Una Mary McVeigh, et autres
Publié: (2021)